Abiopharma

HUTCHMED (CHINA) LTD (HCM)

Symbol	HCM
Name	HUTCHMED (CHINA) LTD
Sector	UNDEFINED
Region	UNDEFINED
Industry	Pharmaceutical Preparations
Address	48TH FLOOR, CHEUNG KONG CENTER, HONG KONG, None None
Telephone	852-2121-3888
Fax	—
Email	—
Website	—
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001648257
Description	None

2026-07-30 11:24

[Press Release] HUTCHMED Reports 2026 Interim Results

2026-07-30 11:00

HUTCHMED Reports 2026 Interim Results

2026-07-02 08:58

[Press Release] HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification

2026-07-02 08:30

HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification

2026-06-30 09:07

[Press Release] HUTCHMED to Announce 2026 Half-Year Financial Results

2026-06-30 08:30

HUTCHMED to Announce 2026 Half-Year Financial Results

2026-06-25 00:05

[Press Release] HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO GI 2026

2026-06-25 00:00

HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026

2026-06-12 00:05

[Press Release] HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

2026-06-12 00:00

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress